Chiu Ya-Lin, Greene Warner C
Gladstone Institute of Virology and Immunology, University of California, San Francisco, CA 94141-9100, USA.
Trends Immunol. 2006 Jun;27(6):291-7. doi: 10.1016/j.it.2006.04.003. Epub 2006 May 4.
To defend against external pathogens, metazoan organisms have evolved numerous defenses that generally fall within the innate and adaptive immune responses. Considerable effort continues to focus on developing a vaccine to manipulate the adaptive immune system to protect against or control HIV-1. However, recent advances in our understanding of the innate immune system have revealed that cells have a potent intrinsic antiretroviral defense in the form of APOBEC3G, which is a member of a larger family of cytidine deaminases that are active against HIV-1 and other retroviruses. Insights into how the action of A3G is circumvented by HIV-1 through the action of its Vif protein, and the surprising mechanisms by which A3G is regulated within the cell, offer exciting new opportunities for developing novel anti-HIV-1 therapies that exploit this intrinsic antiretroviral system.
为抵御外部病原体,后生动物进化出了多种防御机制,这些机制通常可分为固有免疫反应和适应性免疫反应。人们持续投入大量精力研发疫苗,以操控适应性免疫系统来预防或控制HIV-1。然而,我们对固有免疫系统认识的最新进展表明,细胞具有一种强大的内在抗逆转录病毒防御机制,其形式为载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G),它是一个更大的胞苷脱氨酶家族的成员,该家族对HIV-1和其他逆转录病毒具有活性。对于HIV-1如何通过其Vif蛋白的作用规避A3G的作用,以及A3G在细胞内被调控的惊人机制的深入了解,为开发利用这种内在抗逆转录病毒系统的新型抗HIV-1疗法提供了令人兴奋的新机会。